Use patterns and self-reported effects of Salvia divinorum: an internet-based survey

Drug and Alcohol Dependence
Matthew J BaggottJohn E Mendelson

Abstract

There is growing use of Salvia divinorum (SD), a psychoactive plant that produces hallucinogen-like effects through a kappa opioid receptor (KOR) mechanism. Little is known about KOR agonist effects in humans and about users of SD. To characterize the reasons, methods, and reported consequences of SD use. Individuals reading SD-related pages of a drug-information website were invited to anonymously complete an online questionnaire if they had used SD. Participants (N=500) were 92.6% male and 23.4 ± 8.7 (mean ± s.d.) years old. They had used a median of six times (range 1-250). 80.6% probably or definitely would use SD again. Most participants (92.6%) typically smoked or vaporized SD product. When smoked, the drug's main effects were estimated to last 14.1 ± 12.8 (range 0.5-120) minutes. When asked to compare SD effects to other methods of altering consciousness, the most common answer was that SD was unique (38.4%). 25.8% reported persisting (≥ 24 h) positive effects (often described as increased sense of well-being) on at least one occasion. 4.4% reported persisting negative effects (most often anxiety). SD is typically smoked, acute effects are brief, and persistent adverse effects are uncommon. In addition to acute hallucino...Continue Reading

References

Jul 1, 1989·British Journal of Pharmacology·N AshtonT P Blackburn
Aug 15, 1986·Science·A PfeifferH M Emrich
Jan 1, 1967·Current Psychiatric Therapies·J H Jaffe
Jun 1, 1994·Journal of Ethnopharmacology·D J Siebert
Jan 1, 1996·The British Journal of Psychiatry : the Journal of Mental Science·K M AbelR M Murray
Mar 1, 1996·Neuroscience Letters·R W GearJ D Levine
Jun 22, 2001·Drug and Alcohol Dependence·R M Craft, S A Bernal
Jan 5, 2002·Journal of Clinical Psychopharmacology·K R Hanes
May 17, 2002·Progress in Neurobiology·Brigitte L Kieffer, Claire Gavériaux-Ruff
Aug 23, 2002·Proceedings of the National Academy of Sciences of the United States of America·Bryan L RothRichard B Rothman
Oct 3, 2002·Neuropeptides·C Gavériaux-Ruff, B L Kieffer
Jan 30, 2003·Journal of Medical Internet Research·Gunther Eysenbach, Jeremy Wyatt
Mar 22, 2003·The Journal of Pharmacology and Experimental Therapeutics·Stephen D MagueWilliam A Carlezon
Mar 29, 2003·Proceedings of the National Academy of Sciences of the United States of America·Jeffrey S MogilRoger B Fillingim
May 1, 1964·The Journal of Nervous and Mental Disease·H B LINTONI H PAUL
May 18, 2005·Alcoholism, Clinical and Experimental Research·Krisztina M KovacsCsaba Vadasz
May 20, 2005·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Vladimir I CheferToni S Shippenberg
Aug 27, 2005·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Jay P McLaughlinCharles Chavkin
Sep 15, 2005·The Annals of Pharmacotherapy·Cathi E DennehyAmy E Miller
Oct 15, 2005·The Journal of Pharmacology and Experimental Therapeutics·William A CarlezonBruce M Cohen
Apr 1, 2006·Alcoholism, Clinical and Experimental Research·Agustin Zapata, Toni S Shippenberg
May 25, 2006·Drug and Alcohol Dependence·Débora GonzálezManel J Barbanoj
Aug 23, 2006·Genes, Brain, and Behavior·A S Beadles-Bohling, K M Wiren
Aug 23, 2006·Molecular Psychiatry·X XueiH J Edenberg
May 12, 2007·Addiction·Sundeep Singh
Dec 21, 2007·Drug and Alcohol Dependence·James E LangeJohn D Clapp
Sep 5, 2008·Forensic Science International : Synergy·Kenji TsujikawaHiroyuki Inoue
Nov 13, 2008·The Journal of Pharmacology and Experimental Therapeutics·Eduardo R ButelmanMary Jeanne Kreek
Jan 23, 2009·Journal of Drug Education·David N KheyO Hayden Griffin
Feb 6, 2009·The Journal of Clinical Psychiatry·Michael Paulzen, Gerhard Gründer
Feb 13, 2009·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Jennifer A DinieriWilliam A Carlezon
Sep 22, 2009·The Journal of Emergency Medicine·Rais VohraRichard F Clark
Dec 25, 2009·Drug and Alcohol Dependence·James E LangeJohn D Clapp

❮ Previous
Next ❯

Citations

Nov 9, 2012·Psychopharmacology·Katherine A MacLeanRoland R Griffiths
Jan 25, 2012·Journal of Medical Toxicology : Official Journal of the American College of Medical Toxicology·Christopher D RosenbaumKavita M Babu
Jan 1, 2014·Pediatric Emergency Care·Matthew D Thornton, Carl R Baum
Dec 1, 2011·The Journal of Pharmacology and Experimental Therapeutics·S Stevens NegusKenner C Rice
Mar 30, 2011·Pharmacological Reviews·Christopher W CunninghamThomas E Prisinzano
May 23, 2012·Case Reports in Medicine·C R TravisK F Marlowe
Aug 6, 2014·Forensic Science International : Synergy·Fernando Xavier MoreiraPaula Guedes de Pinho
Dec 1, 2015·Asia-Pacific Psychiatry : Official Journal of the Pacific Rim College of Psychiatrists·Rathi MahendranMunidasa Winslow
Mar 19, 2014·Disease-a-month : DM·Michael E NelsonSteven E Aks
Nov 28, 2013·Emergency Medicine Clinics of North America·Michael E NelsonSteven E Aks
May 20, 2015·Drug and Alcohol Dependence·Anders Ledberg
Jul 20, 2011·Journal of Psychosocial Nursing and Mental Health Services·Nancy R Ahern, Cindy S Greenberg
Jan 15, 2013·Journal for the Scientific Study of Religion·Katherine A MacleanRoland R Griffiths
Jun 25, 2013·Human Psychopharmacology·Jolanta B Zawilska, Jakub Wojcieszak
Mar 27, 2013·The Journal of Emergency Medicine·Lucas A JohnsonRay-Bernard Portier
Jul 24, 2013·Neuroscience and Biobehavioral Reviews·Desirée B SpronkRobbert J Verkes
Oct 22, 2016·The International Journal on Drug Policy·Sanna Rönkä, Anu Katainen
Feb 19, 2015·Journal of Psychopharmacology·Peter H AddyJenny Wade
Feb 18, 2016·Journal of Psychopharmacology·Matthew W JohnsonRoland R Griffiths
Oct 31, 2018·Community Mental Health Journal·Antoine KaramFrancois Kazour
Oct 7, 2010·Psychopharmacology·HeeSeung LeeBruce R Russell
Aug 26, 2019·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·John van StekelenborgMunir Pirmohamed
Feb 6, 2017·JMIR Public Health and Surveillance·Laurie S AndersonNabarun Dasgupta
Feb 7, 2021·Pharmaceuticals·Andreia Machado Brito-da-CostaÁurea Madureira-Carvalho
Aug 17, 2021·Journal of Clinical Pharmacology·Kristin Waters
Nov 10, 2020·ACS Chemical Neuroscience·R Bruno Hernández-AlvaradoKarina Martinez-Mayorga

❮ Previous
Next ❯

Related Concepts

Related Feeds

Addiction

This feed focuses mechanisms underlying addiction and addictive behaviour including heroin and opium dependence, alcohol intoxication, gambling, and tobacco addiction.

Autoimmune Polyendocrinopathies

Autoimmune polyendocrinopathies, also called polyglandular autoimmune syndromes (PGASs), or polyendocrine autoimmune syndromes(PASs), are a heterogeneous group of rare diseases characterized by autoimmune activity against more than one endocrine organ, although non-endocrine organs can be affected. Discover the latest research on autoimmune polyendocrinopathies here.

Autoimmune Polyendocrine Syndromes

This feed focuses on a rare genetic condition called Autoimmune Polyendocrine Syndromes, which are characterized by autoantibodies against multiple endocrine organs. This can lead to Type I Diabetes.